Avanos Medical (NYSE:AVNS) shares ticked up today on first-quarter results that just about matched the consensus forecast.
The Alpharetta, Georgia–based pain management and chronic care device company posted profits of $5.8 million, or 12¢ per share, on sales of $197.4 million for the three months ended March 31, 2022, for a bottom-line gain from losses of $7.6 million this time last year on sales growth of 9.2%.
Adjusted to exclude one-time items, earnings per share were 26¢, registering level with projections on Wall Street, where analysts were looking for sales of $197.8 million.
